Archive for the ‘Testing’ Category

Complaint Against Dr. Paul Gisbert Auwaerter License Number: D0041413

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/33656237?

Complaint against Dr. Paul Gisbert Auwaerter License Number: D0041413

Carl Tuttle
Hudson, NH, United States
Jun 27, 2025

Please see the following complaint submitted to the Maryland Board of Physicians along with their response. I followed up in disgust as the disinformation continues year after year decade after decade by the same deceitful individuals who have been propagating the false Lyme disease narrative.

If you agree with my complaint, please voice your concerns by writing to Wes Moore, Governor of Maryland where Dr Paul Auwaerter practices medicine. Reference this Petition Update link and lets flood his inbox with emails! (No matter where you live!!)

governor.mail@maryland.gov

lt.governor@maryland.gov

Picture of Governor Moore found here: https://www.mbp.state.md.us/

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “mdh.mbp_intake@maryland.gov” <mdh.mbp_intake@maryland.gov>
Cc: “oag@oag.state.md.us” <oag@oag.state.md.us>, “cquattrocki@oag.state.md.us” <cquattrocki@oag.state.md.us>, “musa.eubanks@oag.state.md.us” <musa.eubanks@oag.state.md.us>
Date: 06/21/2025 7:56 AM EDT
Subject: Complaint against Dr. Paul Gisbert Auwaerter License Number: D0041413

June 21, 2025

Maryland Board of Physicians
Complaint Intake Unit
4201 Patterson Avenue
Baltimore, MD 21215

Re: Dr. Paul Gisbert Auwaerter, License Number: D0041413

To whom it may concern,

I would like to file a complaint against Dr. Paul Gisbert Auwaerter for propagating false/misleading statements regarding the testing and treatment of tick-borne diseases as there exists a substantial risk of serious harm to public health, safety, and welfare from his misinformation.

Please see the following correspondence with Dr Auwaerter and Medscape’s Editorial Staff regarding the misinformation Auwaerter has been allowed to spread (and viewed by physicians across the country) essentially downplaying the threat of tick-borne disease co-infections while claiming serology for Lyme disease is a “good test.” This deliberate misrepresentation is an ethical concern as Auwaerter, past president of the Infectious Diseases Society of America, is considered an “expert” in the field.

This is not an isolated case. The IDSA has had a history of misinformation; In 2021, the Patient Centered Care Advocacy Group demanded the removal of an inaccurate statement by the IDSA which excluded maternal-fetal transmission of Lyme disease. Congenital transmission was fist described in 1985.

Advocate asks IDSA to remove false statement about Lyme transmission
https://www.lymedisease.org/fries-idsa-remove-false-statements/

Auwaerter was the lead author of the deplorable Lancet Infectious Disease article:

Antiscience and ethical concerns associated with advocacy of Lyme disease
https://pubmed.ncbi.nlm.nih.gov/21867956/

Please consider sending a cease-and-desist letter to Dr. Auwaerter demanding an end to his engaging in this harmful misinformation campaign and require a correction and/or retraction of the statements identified in the correspondence that follows.

A response to this complaint is requested.

Respectfully submitted,

Carl Tuttle
Independent Researcher
Hudson, NH

Cc: Anthony G. Brown, Attorney General
Carolyn A. Quattrocki, Chief Deputy Attorney General
Musa L. Eubanks, Principal Counsel Maryland Department of Health

Correspondence with Dr Auwaerter and Medscape’s Editorial Staff:

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “pauwaert@jhmi.edu” <pauwaert@jhmi.edu>, “pgauwaerter@gmail.com” <pgauwaerter@gmail.com>
Cc: “aaguilar@webmd.net” <aaguilar@webmd.net>, “DFlapan@Medscape.net” <DFlapan@Medscape.net>, “lkane@medscape.net” <lkane@medscape.net>, “gamiller@medscape.net” <gamiller@medscape.net>, “dolmos@webmd.net” <dolmos@webmd.net>, “sarah.wright@webmd.net” <sarah.wright@webmd.net>, “editor2@webmd.net” <editor2@webmd.net>, “mmcnutt@nas.edu” <mmcnutt@nas.edu>, “jliao@nas.edu” <jliao@nas.edu>, “news@medscape.net” <news@medscape.net>
Date: 06/15/2025 12:13 PM EDT
Subject: Medscape: Chronic Lyme Infection-Associated Illness in Urgent Need of Symptom-Targeted Treatments

June 15, 2025

The IDSA Foundation
1300 Wilson Boulevard Suite 300
Arlington, VA 22209
Attn:  Paul Auwaerter, vice chair of the IDSA Foundation

Dr Auwaerter,

I would like to call attention to the following Medscape article referencing the recent National Academies of Sciences review of Lyme disease through a recommendation of the Tick Borne Disease Working Group calling for a review of all the literature.

Medscape Medical News June 10, 2025

Chronic Lyme Infection-Associated Illness in Urgent Need of Symptom-Targeted Treatments
https://www.medscape.com/viewarticle/chronic-lyme-infection-associated-illness-urgent-need-2025a1000fhv

Regarding laboratory testing…

“The current two-tier serologic testing approach based on the Dearborn criteria has limitations and may not detect all cases of Lyme disease, particularly in patients with early or late disease or those who remain symptomatic after treatment.”

In contrast Dr. Auwaerter you continue to promote serology as a “Good Test” with your recent recorded interview for the so-called “Clinician Toolkit” promoted by the American Medical Association which just so happened to be paid five million dollars to buy into this misinformation through CDC grant#  NU50CK000597

Oct 3, 2024
Improving Care for Patients with Prolonged Symptoms and Concerns about Lyme Disease: A Clinician Toolkit 
https://www.ama-assn.org/delivering-care/public-health/improving-care-patients-prolonged-symptoms-and-concerns-about-lyme

Imbedded recording:

Understanding Lyme Disease with Dr. Paul Auwaerter (@12:30 into the recording)

“If you have symptoms for more than a few weeks it’s a very good test and I think there’s a common misconception it’s not a good test. And what is true is it’s not a good test if you’ve only been infected for a week or two because the body hasn’t mounted enough time to develop antibodies. But if people have had symptoms for three, four weeks or longer, it is a good blood test to help assess these later symptoms that could be neurologic, muscular, skeletal, or occasionally cardiac.” – Paul Auwaerter

Serology is so unreliable that in 2013 Virginia Governor Bob McDonnell signed HB1933 into law requiring healthcare providers to notify those tested that current laboratory testing can produce false negatives.

Governor Chris Sununu’s 2020-2021 commission to study diagnostic testing for Lyme disease concluded that the FDA approved two-tier serologic immunoassay for Lyme was not reliable in all stages of disease; no better than a coin toss.

Peer-reviewed evidence of “Seronegativity in Lyme borreliosis and Other Spirochetal Infections” 16 September 2003
https://www.dropbox.com/s/3d6m45jzlhhwalu/Seronegativity.pdf?dl=0

And yet Dr. Auwaerter you continue to promote serology as a “good test”

Furthermore, you refused to answer my inquiry regarding your Medscape commentary of Oct 2023

Medscape COMMENTARY

New Federal Oversight of Lab Developed Tests
https://www.medscape.com/viewarticle/997365

Excerpt:

“I often see patients who are concerned they might have Lyme disease, or they’ve been told by other physicians that they have a tickborne or multiple infections. I’ve had patients who claim to have five or six infections: Lyme disease, Babesia, Bartonella, Mycoplasma, or Epstein-Barr virus. They bring LDT results from outside laboratories, which often have a proviso that these tests are only for research or educational purposes. Yet, they purport finding analytes (antibodies or proteins) that suggest the patient has an active infection. These patients may have been treated but are not improving, so they are referred to me.” – Paul Auwaerter

Carl Tuttle’s Inquiry: (which remains unanswered and posted to that commentary)

Dr. Auwaerter… I would like to call attention to the following 2009 tick study conducted here in New Hampshire:
 
Correlation between Tick Density and Pathogen Endemicity, New Hampshire
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671416/
 
The study found deer ticks were carrying multiple pathogens (co-infections) that could be transmitted in a single bite.
 
What FDA approved Tick-Borne Disease Panel are you recommending so as not to miss any of these infections?
 
A response to this inquiry is requested.
 
Carl Tuttle
Hudson, NH
___________________

Dr. Auwaerter,

Are you aware of the following announcement? IGeneX is finding those “multiple infections” you claim do not exist….

IGeneX Lyme ImmunoBlot test kit receives FDA clearance
https://www.lymedisease.org/lyme-immunoblot-fda-clearance/

GETTING STARTED WITH IGENEX
https://igenex.com/wp-content/uploads/getting-started-with-igenex.pdf

A 2018 study of 10,000+ patient samples from nearly every state:
 
37.3% were positive for Babesia species
32.1% for Lyme Borrelia
27.7% for TBRF Borrelia
19.1% for Bartonella
16.7% for Anaplasma
12.8% for Rickettsia
6.9% for Ehrlichia

Co-infections:

40% tested positive for two pathogens
15% tested positive for three pathogens
4.6% tested positive for four pathogens
0.7% tested positive for five pathogens

What is going on here Dr. Auwaerter? Are you completely uninformed or deliberately promoting misinformation? Will you be correcting/retracting your statements?

A response to this inquiry is requested.

Carl Tuttle
Independent Researcher
Hudson, NH

Cc: MEDSCAPE EDITORIAL STAFF
Marcia McNutt, President of the National Academy of Sciences and Chair of the National Research Council
Send comments and news tips to news@medscape.net

_________________________________________________________________

To the Maryland Board of Physicians:

Additional complaints against Auwaerter:
 
1. The Mayday Project Responds to Dr. Paul Auwaerter’s Defense of IDSA Guidelines for Lyme Disease
https://www.webwire.com/ViewPressRel.asp?aId=192558

2. Hopkins Physician Says Lyme Disease Patients Create Conspiracy Theories About Their Illnesses
https://www.webwire.com/ViewPressRel.asp?aId=197392

3. Mothers Against Lyme Calls for Retraction of False Information on Congenital Lyme in IDSA, AAN, ACR Guidelines
Retraction request cites harm to pregnant women and children
https://www.webwire.com/ViewPressRel.asp?aId=281005

4. Detailed patient experience because of the false information (Please read)
https://www.facebook.com/photo/?fbid=30451510191160844

Excerpt:

“I’ve tried explaining this a few times and I won’t stop until people get it. This isn’t like cancer or any other disease where I can go to a Dr that’s covered by my insurance and receive treatment. What is happening here is criminal and if you don’t believe me, ask ANYONE with Lyme.”

Response from the Maryland State Board of Physicians

———- Original Message ———-
From: MDH mbp_intake -MDH- <mdh.mbp_intake@maryland.gov>
To: CARL TUTTLE <runagain@comcast.net>
Date: 06/26/2025 11:09 AM EDT
Subject: Re: Complaint against Dr. Paul Gisbert Auwaerter License Number: D0041413

Good morning, Mr. Tuttle:

Please see the attached.

Thank you,
Intake Unit
Maryland State Board of Physicians

The Board of Physicians is committed to customer service.  Please visit https://www.doit.state.md.us/selectsurvey/TakeSurvey.aspx?agencycode=MBP&SurveyID=86M2956 to take our Customer Satisfaction Survey.

My reply to the Maryland State Board of Physicians:

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: MDH mbp_intake -MDH- <mdh.mbp_intake@maryland.gov>, “jennifer.saylor-florio@maryland.gov” <jennifer.saylor-florio@maryland.gov>
Cc: “Harbhajan.Ajrawat@maryland.gov” <Harbhajan.Ajrawat@maryland.gov>, “Christine.Farrelly@maryland.gov” <Christine.Farrelly@maryland.gov>, “hajrawat@gmail.com” <hajrawat@gmail.com>, “oag@oag.state.md.us” <oag@oag.state.md.us>, “cquattrocki@oag.state.md.us” <cquattrocki@oag.state.md.us>, “governor.mail@maryland.gov” <governor.mail@maryland.gov>, “lt.governor@maryland.gov” <lt.governor@maryland.gov>
Date: 06/27/2025 8:31 AM EDT
Subject: Re: Complaint against Dr. Paul Gisbert Auwaerter License Number: D0041413

Intake Unit
Maryland State Board of Physicians,
via   <jennifer.saylor-florio@maryland.gov>

Dr. Saylor-Florio,

I would like to call attention to the following statement found in the attached response to my complaint against Dr Paul Auwaerter:

“The Board of Physicians is responsible for assuring that licensed physicians and allied health practitioners render competent medical care to the citizens of Maryland”

Isn’t that statement a bit hypocritical when you allow a physician to claim serology for Lyme disease is a “good test” when in fact it is no better than a coin toss while using his position of authority as past president of the IDSA to propagate that falsehood?

I question the credibility of this medical board willing to turn a blind eye to Auwaerter’s misleading statements. How could he possibly provide competent medical care believing that serology is a good test while tick-borne co-infections are of little concern? The potential for harm or negative outcomes is substantial and noteworthy.

Carl Tuttle
Independent researcher
Hudson, NH

Cc: Harbhajan Ajrawat, M.D. Chair
Anthony G. Brown, Attorney General
Carolyn A. Quattrocki, Chief Deputy Attorney General
Wes Moore, Governor
Aruna Miller Lt Governor

_______________

**Comment**

I find it quite telling that the Maryland Board of Physicians claims it does not have legal authority to investigate Dr. Auwaerter’s patently false statements about Lyme testing.  State Boards over Physicians had no trouble whatsoever investigating and persecuting any doctor during COVID who advocated for treatments (ivermectin, HCQ, vitamins, etc.) other than what the top-down accepted narrative had to offer (ventilators, remdesivir, the clot shot, etc), or whom questioned the clot shot gene therapy which was touted as ‘safe and effective,” like a mantra.

Do not expect justice from these ‘professional’ medical groups.

They are on the wrong side of the fence.

For More:

Category:

Activism, Lyme, Testing

Minnesota Woman With Chronic Lyme Shares Misdiagnosis Story

http://

Woman with chronic Lyme disease shares misdiagnosis story | Talking Points

I get it.  I really do. 

Testing for Lyme disease is a black hole without end.

I’m so jaded I personally don’t put any stock whatsoever into testing for tick-borne infections. They are a waste of time and money – particularly since chronic patients need to carefully plan where they decide to put their pennies as money will be flowing out their pockets for years.

If you want to understand testing, you must also understand the sordid Lyme disease vaccine history at Dearborn, Michigan:  https://madisonarealymesupportgroup.com/2020/02/10/the-bitter-feud-over-lymerix/

In short, two Bb proteins OspA and OspB which are the most specific for Lyme disease were removed from testing due to the fact they interfered with Lyme vaccine development.  

An issue that has NEVER been resolved.

Testing:

Category:

Activism, Lyme, Testing

Truth About WHO Treaty – U.S. Must Opt Out of IHR by July 19, 2025

http://  Approx. 24 Min

WHO Pandemic Treaty

‘It’s Worse Than We Thought’

May 28, 2025

Members of Congress gave a letter to Biden in 2022 calling on him to exit the WHO, but only recently has Trump promised to withdraw from the corrupt organization.  Despite this, every country, including the U.S., is still on the hook unless they opt out of the WHO’s International Health Regulations (IHR) by July 19, 2025.

According to this, the agreement centers on something called the PABS system, a global plan to share profits from so-called “pandemic pathogens.”
“They literally talk about pathogens with pandemic potential,” Roguski said. “They don’t need to have an actual outbreak.”
Roguski warns their goal is to build permanent mRNA infrastructure, fast-track approvals, and hand out billions in contracts—before a single case is reported.
If the U.S. doesn’t opt out, the WHO has the power to sniff around for money to be used in this gigantic, global money laundering business deal to make Big Pharma even bigger.
It will allow the fraudulent PCR to be used in “One Health” – so inspectors will show up to test every animal using a test that virtually everything tests positive.
Not only does the U.S. need to opt out of ALL things WHO, the WHO needs to be eliminated.  It’s nothing but a money laundering business plan to use up tax dollars on things that don’t affect health one iota.

For more:

Category:

Activism, Testing, Treatment, vaccines, Viruses

Massachusetts Man Dies From Tick-Borne Powassan Virus

https://www.lymedisease.org/massachusetts-powassan-death/

Massachusetts man dies from tick-borne Powassan virus

May 15, 2025

Kevin Boyce, a 62-year-old resident of the Boston area, passed away last year from Powassan virus. Now, his family is raising awareness about the risks of tick bites and urging people to take precautions.

Boyce fell ill in April 2024. Within days, his condition worsened, leading to hospitalization and a diagnosis of Powassan virus, which can cause severe brain inflammation. Despite intensive care, he succumbed to the disease several weeks later.

His family hopes to prevent similar tragedies by encouraging early detection, tick prevention measures, and public awareness. Watch this report from NBC10, Boston.

For More:

Category:

Testing, Ticks, Transmission, Viruses

Why Doctor Treated Patient for Lyme – Even When His Test Was Negative

https://danielcameronmd.com/treated-lyme-negative-test/

Why I Treated Him for Lyme—Even When His Test Was Negative

Posted By: Dr. Daniel Cameron
May 13, 2025

Patients Deserve an Explanation

One of the most common—and most important—questions I hear from patients is:
“If my Lyme test is negative, why are you still treating me?”

It’s a fair question. And if you’re asking it, you deserve a clear and compassionate answer. The truth is, when it comes to Lyme disease, test results don’t always tell the full story.

Let’s break down why.

Lyme Disease Testing Isn’t Always Reliable

The standard test used to diagnose Lyme disease is called the two-tier system. It includes an ELISA screening test followed by a Western blot if the first result is positive. But this system is far from perfect—especially when the infection is in its early or late stages.

Here’s what you should know:

  • Early in the infection, your body may not have produced enough antibodies yet to trigger a positive result
  • Some patients never produce detectable antibodies at all
  • Co-infections like Babesia or Bartonella are not picked up by this test
  • Many rashes don’t appear in the textbook “bulls-eye” pattern—or don’t appear at all
So yes—you can absolutely have Lyme disease, even if your test is negative. And unfortunately, this is more common than many realize.

In Medicine, We Don’t Wait for Disease to Get Worse

In most areas of healthcare, we don’t wait for a serious event before we start treatment.

  • We don’t wait for a stroke to treat high blood pressure
  • We don’t wait for vision loss to manage diabetes
  • We don’t wait for full organ failure to address chronic kidney disease

We act early—because we know that early treatment improves outcomes. So why does Lyme disease often get treated differently?

When it comes to Lyme, many patients are told to “wait and see”—even when the symptoms are clear and distressing.

Waiting Is Not a Neutral Decision

Here’s what I tell my patients:
Waiting is not harmless. It’s a medical decision with consequences.

Delaying treatment can allow symptoms to worsen. It can allow the infection to persist or spread. In some cases, patients who were told to wait eventually end up with a label: Post-Treatment Lyme Disease Syndrome (PTLDS)—a condition where symptoms linger long after the initial infection was treated, or in some cases, never properly treated at all.

What if we had treated earlier? Could we have prevented months—or even years—of suffering?

In many cases, the answer is yes.

Clinical Judgment Is Not Guesswork

When I decide to treat someone for Lyme disease despite a negative test, it’s not a random decision. It’s based on:

• The full pattern of your symptoms

• Your medical history

• Your response to prior treatments

• Known or likely tick exposure

• And experience with thousands of Lyme patients

This is called clinical judgment. It’s a core part of good medical practice. I don’t ignore science—I apply it in context. Because Lyme doesn’t always follow the rules, and neither should we when those rules are failing real people.

You Know When Something Feels Wrong

I’ve met patients who’ve been told their symptoms are “just stress” or “hormonal” or “all in their head.” But they know their bodies. They’ve tracked their fatigue, their joint pain, their cognitive changes. They’ve seen something shift—and they’re right to speak up about it.

Many of those patients improve once treatment begins, even if their test results never confirmed the diagnosis. That’s not luck. That’s Lyme disease showing up in real life—even when it doesn’t show up in the lab.

It’s Time to Rethink How We Treat Lyme

We’re in a new era of medicine. Patients are more informed, more proactive, and more in tune with their own health than ever before. But too often, our Lyme diagnostic standards are stuck in the past—waiting for certainty while people lose months or years of their lives to untreated illness.

We need to bring clinical judgment back into focus. We need to listen more, wait less, and treat Lyme disease with the urgency it deserves.

Final Thoughts

If you’ve been told your test is negative, but you’re still struggling with symptoms—please know this:
You’re not imagining it. You’re not overreacting. And you’re not alone.

In my practice, I treat the whole patient—not just the lab result. Because when it comes to Lyme, early treatment can change everything.

Want to learn more? Follow my blog series for more insights on Lyme disease diagnosis and care—or reach out to my office if you’re looking for answers.
You deserve to be heard.

Related Articles:

Relying on a negative Lyme disease test can prove deadly

Don’t wait for a positive Lyme disease test

Can’t trust single dose of doxycycline to prevent Lyme disease

_______________

**Comment**

A very needed article with crucial information for all to understand.

Testing for Lyme/MSIDS is abysmal.  Clinical judgement is required; however, doctors receive little training for tick-borne infections and whatever training they do receive is antiquated and biased.  The fact the needle hasn’t budged in 40 years is proof of this fact.

Dr. Cameron is an example of an independent doctor who could save your life.  He’s also a Lyme-literate doctor who has studied under ILADS and who has years of experience treating this.  Like many of his colleagues, he’s been attacked by the state medical board – which is common for these doctors because they do not partake in the globalist idea for ‘consensus-based’ medicine – which turns doctors into robots who blindly follow dictates from bureaucrats who are profiting from conflicts of interests including patents, drugs, and other metabolomics. 

Due to the horrific lack of education on all things Lyme/MSIDS, there is a parallel group to the tyrannical IDSA (Infectious Diseases Society of America) called ILADS (International Lyme and Associated Diseases Society) which holds their own medical conferences to educate doctors on what is happening in reality with Lyme/MSIDS and through independent, global research that the IDSA simply ignores or maligns. Their next conference, “The Complexity of Lyme: Diagnosing and Treating Tick-Borne and Related Diseases,” is June 7-8 in Philadelphia.

Our conference will include:

  • Introduction to diagnosing and treating vector-borne diseases
  • Case discussions with experts
  • Advanced topics in clinical treatments such as PANS/PANDAS, Mold toxicity, MCAS, supportive natural therapies and more.
  • Exhibitors showcasing medical services
  • CME credit available

The conference is open to healthcare professionals. Students enrolled in a medical degree program and PhD candidates conducting Lyme-related research are also eligible to attend and qualify for discounted rates. Email conference@ilads.org for more information.

Category:

Lyme, research, Testing, Treatment